Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (21-30 of 385) with videos related to

Pageof 39
Sort By:
Reviews in Clinical and Experimental Hematology|July 20, 2005
Genomics in myeloid leukemias: an array of possibilitiesLars Bullinger, Hartmut Döner, Jonathan R Pollack
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2025
Combination of Long-Read Sequencing and Hi-C Technology to Identify Chromoanagenesis Events in CancerMarius-Konstantin Klever, Julius Jungnitsch, Lars Bullinger
Acta Haematologica|May 26, 2023
The Recurrent Atypical e8a2 BCR::ABL1 Transcript with Insertion of an Inverted 55 Base Pair ABL1 Intron 1b Sequence: A Detailed Molecular AnalysisThomas Burmeister, Lars Bullinger, Philipp le Coutre
Expert Review of Hematology|March 16, 2018
Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemiaStephan R Bohl, Lars Bullinger, Frank G Rücker
International Journal of Molecular Sciences|April 26, 2019
New Targeted Agents in Acute Myeloid Leukemia: New Hope on the RiseStephan R Bohl, Lars Bullinger, Frank G Rücker
Future Oncology (London, England)|October 6, 2010
DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insightsRainer Claus, Christoph Plass, Scott A Armstrong, et al.
JACC. Cardiooncology|February 19, 2025
Growth Differentiation Factor-15: A Promising Biomarker and Target in Cancer PatientsMarkus S Anker, Lars Bullinger, Ulrich Keller, et al.
Oncology Research and Treatment|April 18, 2019
Retroperitoneal Hematoma after Bone Marrow Biopsy: The First Cut Should Not Be the DeepestAndrej Wojciechowski, Martin Duckert, Jens Hartmann, et al.
Cancers|September 28, 2023
Mechanisms of Resistance to Small Molecules in Acute Myeloid LeukemiaTonio Johannes Lukas Lang, Frederik Damm, Lars Bullinger, et al.
Frontiers in Oncology|May 6, 2026
Case Report: Use of mirvetuximab soravtansine in a patient with platinum-resistant ovarian cancer and concomitant PARP-inhibitor-related myelodysplastic syndromeSophonie Shilonite Njonou Noujiep, Judith Altmann, Lars Bullinger, et al.
Pageof 39

Showing results (21-30 of 385) with videos related to

Sort By:
Pageof 39
Reviews in Clinical and Experimental Hematology|July 20, 2005
Genomics in myeloid leukemias: an array of possibilitiesLars Bullinger, Hartmut Döner, Jonathan R Pollack
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2025
Combination of Long-Read Sequencing and Hi-C Technology to Identify Chromoanagenesis Events in CancerMarius-Konstantin Klever, Julius Jungnitsch, Lars Bullinger
Acta Haematologica|May 26, 2023
The Recurrent Atypical e8a2 BCR::ABL1 Transcript with Insertion of an Inverted 55 Base Pair ABL1 Intron 1b Sequence: A Detailed Molecular AnalysisThomas Burmeister, Lars Bullinger, Philipp le Coutre
Expert Review of Hematology|March 16, 2018
Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemiaStephan R Bohl, Lars Bullinger, Frank G Rücker
International Journal of Molecular Sciences|April 26, 2019
New Targeted Agents in Acute Myeloid Leukemia: New Hope on the RiseStephan R Bohl, Lars Bullinger, Frank G Rücker
Future Oncology (London, England)|October 6, 2010
DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insightsRainer Claus, Christoph Plass, Scott A Armstrong, et al.
JACC. Cardiooncology|February 19, 2025
Growth Differentiation Factor-15: A Promising Biomarker and Target in Cancer PatientsMarkus S Anker, Lars Bullinger, Ulrich Keller, et al.
Oncology Research and Treatment|April 18, 2019
Retroperitoneal Hematoma after Bone Marrow Biopsy: The First Cut Should Not Be the DeepestAndrej Wojciechowski, Martin Duckert, Jens Hartmann, et al.
Cancers|September 28, 2023
Mechanisms of Resistance to Small Molecules in Acute Myeloid LeukemiaTonio Johannes Lukas Lang, Frederik Damm, Lars Bullinger, et al.
Frontiers in Oncology|May 6, 2026
Case Report: Use of mirvetuximab soravtansine in a patient with platinum-resistant ovarian cancer and concomitant PARP-inhibitor-related myelodysplastic syndromeSophonie Shilonite Njonou Noujiep, Judith Altmann, Lars Bullinger, et al.
Pageof 39